Author

Toni Celià-Terrassa

Hospital Del MarORCID 0000-0002-0615-8744Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Aleix Noguera‐CastellsiD· 1 shared Angel Montero CarcabosoiD· 1 shared Ángel RomániD· 1 shared Anna López‐PlanaiD· 1 shared Annika Patthey· 1 shared Carlos Peula· 1 shared Chiara CannatáiD· 1 shared Chuan HeiD· 1 shared

Activity by Year

2021-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aleix Noguera‐CastellsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

METTL3-mediated m6A modification of DNMT1 enhances ovarian cancer progression

Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera‐Castells, Raquel Pluvinet, Carlos Peula, Annika Patthey, Ghazala Naz Khan, Kinga Pajdzik, Ángel Román, Erik Dassi, Chuan He, Eva Lundin, Manel Esteller, Toni Celià-Terrassa, Francesca Aguiló

This study identifies METTL3-mediated m6A modification of DNMT1 as a driver of ovarian cancer progression by enhancing DNMT1 translation and suppressing tumor suppressors.

bioRxiv · Sep 10, 2025 · PreprintCancer Biology

Reconfiguration of tumor cells with LCOR transcription factor mRNA nanotherapy to enhance immunotherapy efficacy

Gabriel Serra-Mir, Elena Haro-Martínez, Chiara Cannatá, José Ángel Palomeque, Sandra Blasco-Benito, Anna López‐Plana, María Sanz‐Flores, Marc Sabartés, Cristina Fornaguera, Toni Celià-Terrassa

This paper develops an mRNA nanotherapy using LCOR to enhance immunotherapy in breast cancer by restoring antigen presentation and reducing tumor growth.

bioRxiv · Apr 2, 2025 · PreprintCancer Biology

Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting metastasis

Lucía Fanlo, Soledad Gómez‐González, Irene Sangrador, Emmanuel L. Gautier, Susana Usieto, Elena Rebollo, Mònica Vilà-Ubach, Angel Montero Carcaboso, Toni Celià-Terrassa, Cinzia Emilia Lavarino, Elisa Martı́, Gwenvaël Le Dréau

The paper identifies a transcriptional signature distinguishing low- and high-risk neuroblastomas and shows that NXPH1/-NRXN signaling inhibits metastasis while promoting tumor growth.

bioRxiv · Nov 26, 2021 · PreprintNeuroscience